crypto it Top Knowledge

Schlegel, Governor of Swiss National Bank: If monetary policy needs to be further relaxed, interest rate reduction is still the main tool. The Swiss National Bank is still willing to intervene in the foreign exchange market when necessary.Alleged of tax evasion, Adidas' German headquarters was raided for two days in a row. On December 11th, local time, criminal prosecutors and customs investigators raided Adidas' German headquarters for the second day in a row, which was an escalation of years of investigation on the sports brand's alleged tax evasion. The amount of tax evasion may exceed 1.1 billion euros. The European Prosecutor's Office (EPPO), headquartered in Luxembourg, said on the 11th that it was conducting a "criminal investigation" against a German sportswear trading enterprise group on the grounds that it was "suspected of tax evasion related to customs duties and import and sales taxes". Adidas said that this long-term investigation is unlikely to have "any significant financial impact".The Syrian Sharm el-Liberation Organization said that it would disband the Syrian government security forces. On December 11th, Giulani, leader of the Syrian Sharm el-Liberation Organization, said in a statement to Reuters that he would disband the Syrian government security forces and close the prison.

Xiamen Tungsten Xinneng: Signed a strategic cooperation framework agreement for solid-state batteries with Xinwangda Power. Xiamen Tungsten Xinneng announced that the company and Xinwangda Power signed the Strategic Cooperation Framework Agreement for Solid-state Batteries on December 11, 2024. The two sides will give full play to their respective advantages in market and technology, promote the industrialization of a series of new energy battery materials for solid-state batteries, establish a deep-seated strategic cooperative relationship, jointly develop a series of new energy battery materials for solid-state batteries, and further expand business cooperation at an appropriate time.Mengke Pharmaceutical Co., Ltd.: The new packaging of Contizontamide tablets will be on the market soon. Mengke Pharmaceutical Co., Ltd. announced that the company has launched Contizontamide tablets with new packaging specifications, and a box of 12 tablets will be on the market soon. Contizontamide tablet is a new class 1 oxazolidinone antibacterial drug with global intellectual property rights. It was approved by National Medical Products Administration, China on June 1st, 2021 for the treatment of complex skin and soft tissue infections.Zhongyuan Expressway: The toll revenue in November was 373 million yuan. Zhongyuan Expressway announced that the toll revenue in November 2024 was 373 million yuan.

Jichuan Pharmaceutical Co., Ltd. and Dongke Pharmaceutical Co., Ltd., a wholly-owned subsidiary, have recently received the Drug Registration Certificate for Children Faropenem Sodium Granules and Cefezoxime Sodium for Injection approved and issued by National Medical Products Administration.Botuo Bio: Adjust the profit distribution plan for the first three quarters of 2024. Botuo Bio announced that the total amount of cash dividends to be distributed in the company's profit distribution for the first three quarters of 2024 was adjusted from RMB 52.2583 million to RMB 53.2083 million. Before the adjustment, the company's total share capital was 105 million shares after deducting the shares in the company's repurchase special securities account, and a total cash dividend of 52.2583 million yuan was planned to be distributed. After adjustment, the company's total share capital is 107 million shares, of which 250,000 shares are repurchased in the special securities account, and the total number of shares actually participating in the profit distribution of the company is 106 million shares, with a total cash dividend of 53,208,300 yuan.Ai Kelan: The actual controller intends to transfer 5% shares of the company by agreement. Ai Kelan announced that Liu Yi, the controlling shareholder and actual controller of the company, intends to transfer 4 million unrestricted shares of the company to Guangdong Nanchuan Private Equity Fund Management Co., Ltd. by agreement transfer, accounting for 5.00% of the company's total share capital. If the transaction is finally completed, Liu Yi holds 33.89% of the company's shares, and Nanchuan Private Equity holds 5.00% of the company's shares. This change in equity will not lead to changes in the controlling shareholder and actual controller of the company. The transfer of shares in this agreement can only be handled in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. after the compliance confirmation of Shenzhen Stock Exchange. The share transfer price of this transaction is 20.61 yuan/share.